Cargando…

Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England

Detalles Bibliográficos
Autores principales:	Jenkins, Claire, Byrne, Lisa, Vishram, Bhavita, Sawyer, Clare, Balasegaram, Sooria, Ahyow, Laura, Johnson, Sally
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2020
Materias:	Personal View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481745/ https://www.ncbi.nlm.nih.gov/pubmed/32552986 http://dx.doi.org/10.1099/jmm.0.001215

Ejemplares similares

Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli serotype O55:H7 in England, 2014–2018
por: Sawyer, C., et al.
Publicado: (2021)

The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England
por: Vishram, Bhavita, et al.
Publicado: (2021)

Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
por: Walsh, Patrick R., et al.
Publicado: (2018)

Ongoing haemolytic uraemic syndrome (HUS) outbreak caused by sorbitol-fermenting (SF) Shiga toxin-producing Escherichia coli (STEC) O157, Germany, December 2016 to May 2017
por: Vygen-Bonnet, Sabine, et al.
Publicado: (2017)

Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
por: Wong, Edwin K.S., et al.
Publicado: (2013)

Outbreak of Shiga toxin-producing Escherichia coli (STEC) O26 paediatric haemolytic uraemic syndrome (HUS) cases associated with the consumption of soft raw cow’s milk cheeses, France, March to May 2019
por: Jones, Gabrielle, et al.
Publicado: (2019)

L-Arginine/NO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)
por: Kanzelmeyer, Nele Kirsten, et al.
Publicado: (2014)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013)

Comparative Genomics to Delineate Pathogenic Potential in Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) from Patients with and without Haemolytic Uremic Syndrome (HUS) in Norway
por: Haugum, Kjersti, et al.
Publicado: (2014)

An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient
por: Manière, Louis, et al.
Publicado: (2019)

Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed
por: Karpman, Diana
Publicado: (2012)

Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report
por: Bally, Stéphane, et al.
Publicado: (2019)

Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: genetic analysis prior to transplantation is essential
por: Dowen, Frances, et al.
Publicado: (2017)

Shiga Toxin–Producing Escherichia coli (STEC)
por: Hunt, John M.
Publicado: (2010)

Haemolytic uraemic syndrome in children England, Wales, Northern Ireland, and Ireland: A prospective cohort study
por: Byrne, Lisa, et al.
Publicado: (2023)

Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013
por: Naseer, U., et al.
Publicado: (2017)

Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009–2012
por: Launders, N, et al.
Publicado: (2016)

POS-041 HAEMOLYTIC URAEMIC SYNDROME (HUS) WITH COVID-19 INFECTION: 2 CASE REPORTS. IS THERE A DIRECT LINK?
por: Maharaj, N., et al.
Publicado: (2021)

Psychiatric Symptoms in Patients with Shiga Toxin-Producing E. coli O104:H4 Induced Haemolytic-Uraemic Syndrome
por: Kleimann, Alexandra, et al.
Publicado: (2014)

Animal and environmental risk factors for sporadic Shiga toxin-producing Escherichia coli (STEC) infection in England: a case control study for O157, O26 and other STEC serotypes
por: Kintz, Erica, et al.
Publicado: (2023)

The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS
por: Feitz, Wouter J. C., et al.
Publicado: (2021)

Soluble plasma VE-cadherin concentrations are elevated in patients with STEC infection and haemolytic uraemic syndrome: a case–control study
por: Doulgere, Julia, et al.
Publicado: (2015)

Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016
por: Bruyand, Mathias, et al.
Publicado: (2019)

Treatment of Shiga-Toxin Hus with Severe Neurologic Features with Eculizumab
por: Umscheid, Jacob H., et al.
Publicado: (2021)

The Role of Escherichia coli Shiga Toxins in STEC Colonization of Cattle
por: Menge, Christian
Publicado: (2020)

Cutaneous involvement in haemolytic uraemic syndrome
por: Neild, G. H., et al.
Publicado: (2013)

Coma caused by Shigella toxin-producing Escherichia coli in the absence of haemorrhagic uraemic syndrome (HUS)
por: Velding, Kristien, et al.
Publicado: (2016)

Recurrent seasonal outbreak of an emerging serotype of Shiga toxin-producing Escherichia coli (STEC O55:H7 Stx2a) in the south west of England, July 2014 to September 2015
por: McFarland, Noëleen, et al.
Publicado: (2017)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Antibiotic resistance and integrons in Shiga toxin-producing Escherichia coli (STEC)
por: Colello, Rocío, et al.
Publicado: (2015)

Advances in detection methods for Shiga toxin-producing Escherichia coli (STEC)
por: Padola, Nora L.
Publicado: (2014)

Application of Bacteriophages on Shiga Toxin-Producing Escherichia coli (STEC) Biofilm
por: Mangieri, Nicola, et al.
Publicado: (2021)

Editorial: Shiga toxin-producing Escherichia coli (STEC) infections and consequences
por: Goldstein, Jorge, et al.
Publicado: (2022)

Shiga toxin-producing Escherichia coli O26:H11 associated with a cluster of haemolytic uraemic syndrome cases in South Africa, 2017
por: Smith, Anthony M., et al.
Publicado: (2019)

Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013)

Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017)

Impact of Shiga-toxin encoding gene transduction from O80:H2 Shiga toxigenic Escherichia coli (STEC) on non-STEC strains
por: Habets, Audrey, et al.
Publicado: (2022)

Fecal diagnostics in combination with serology: best test to establish STEC-HUS
por: Wijnsma, Kioa L., et al.
Publicado: (2016)

Shiga Toxin-Producing Escherichia coli (STEC) Associated with Calf Mortality in Uruguay
por: Fernández, Magalí, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4s2gq9hr9otmhj944vs8ll3e0v